| HGNC Family | Non-coding RNAs |
| Name | microRNA 190b |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNAs, as key regulators of gene expression, have been shown to influence a wide range of biological processes and diseases. miR‑190b, in particular, has emerged as a multifunctional molecule with context‐dependent roles. In gastric cancer, its potential involvement in modulating radio‑sensitivity has been assessed, highlighting a possible role in affecting treatment responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Similarly, in osteosarcoma models, overexpression of miR‑190b inhibited cell proliferation and promoted apoptosis by modulating cell cycle inhibitors and apoptotic factors, underscoring its tumor‑suppressive capacity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the realm of metabolic disease, miR‑190b has been implicated in the pathogenesis of nonalcoholic fatty liver disease. Increased expression of miR‑190b in patient liver tissues and NAFLD models contributed to lipid accumulation and insulin resistance via direct targeting of IGF‑1 and ADAMTS9. Notably, knockdown of miR‑190b alleviated hepatic steatosis and improved insulin signaling, suggesting that its inhibition could be therapeutically beneficial."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn lung cancer models, miR‑190b was identified as a novel tumor suppressor. Its overexpression led to significant suppression of malignant progression through targeting of the Hus1 gene, thereby impeding tumorigenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Furthermore, mechanistic studies in HeLa cells have demonstrated that miR‑190b contributes to endoplasmic reticulum stress‑induced apoptosis by acting as an effector of Xbp1 splicing. The inhibition of miR‑190b attenuated this apoptotic pathway, indicating a crucial role in cell stress responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its functional roles in cellular processes, differential expression of miR‑190b has clinical implications. In endometrial cancer, its expression, together with that of miR‑375, helped distinguish high‑grade tumors from lower‑grade disease, suggesting utility as a grading verification marker."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Likewise, in prostate cancer, significant down‑regulation of miR‑190b in both plasma and tissue samples has been associated with disease progression, supporting its potential as a diagnostic and prognostic biomarker."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Changzheng Wang, Chuanhu Qiao "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-190b confers radio-sensitivity through negative regulation of Bcl-2 in gastric cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biotechnol Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10529-016-2273-2"}], "href": "https://doi.org/10.1007/s10529-016-2273-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28044223"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28044223"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Mingyang Kang, Peng Xia, Tingting Hou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-190b inhibits tumor cell proliferation and induces apoptosis by regulating Bcl-2 in U2OS osteosarcoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmazie (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1691/ph.2017.6921"}], "href": "https://doi.org/10.1691/ph.2017.6921"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29441873"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29441873"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Min Xu, Xi-Ming Zheng, Fang Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.26776"}], "href": "https://doi.org/10.1002/jcb.26776"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29575055"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29575055"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hui Hong, Shun Yao, Yuanyuan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1009168"}], "href": "https://doi.org/10.1371/journal.pgen.1009168"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33137086"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33137086"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Roberto Ambra, Sonia Manca, Guido Leoni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of miR-190b in Xbp1 mRNA Splicing upon Tocotrienol Treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Molecules (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/molecules26010163"}], "href": "https://doi.org/10.3390/molecules26010163"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33396504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33396504"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Miłosz Pietrus, Michał Seweryn, Przemysław Kapusta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Low Expression of miR-375 and miR-190b Differentiates Grade 3 Patients with Endometrial Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomolecules (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/biom11020274"}], "href": "https://doi.org/10.3390/biom11020274"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33668431"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33668431"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Mohd Mabood Khan, Mohammad Serajuddin, Mausumi Bharadwaj "}, {"type": "b", "children": [{"type": "t", "text": "Potential plasma microRNAs signature miR-190b-5p, miR-215-5p and miR-527 as non-invasive biomarkers for prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomarkers (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/1354750X.2022.2163694"}], "href": "https://doi.org/10.1080/1354750X.2022.2163694"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36644827"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36644827"}]}]}]}
|
| Synonyms | MIR-190B, MIRN190B |
| NCBI Gene ID | 100126346 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR190B has 387 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 14 datasets.
Click the + buttons to view associations for MIR190B from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR190B gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR190B gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR190B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR190B gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR190B gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR190B gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR190B gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR190B gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR190B gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR190B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR190B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR190B gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR190B gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR190B gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |